These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6274572

  • 21. Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
    Johnston CI, Jackson BJ, Larmour I, Cubella R, Casley D.
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):233S-239S, 241S. PubMed ID: 6099738
    [Abstract] [Full Text] [Related]

  • 22. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH, Man in 't Veld AJ, Admiraal PJ, Ritsema van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA.
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [Abstract] [Full Text] [Related]

  • 23. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB, Desponds G, Biollaz J, Keller I, Ferber F, Gavras H, Brunner HR, Schelling JL.
    Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131
    [Abstract] [Full Text] [Related]

  • 24. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.
    Stumpe KO, Overlack A, Kolloch R, Schatz J, Witte PU, Pahnke K.
    Klin Wochenschr; 1986 Jun 16; 64(12):558-62. PubMed ID: 3016405
    [Abstract] [Full Text] [Related]

  • 25. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Jun 16; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 26. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ, Lees KR, Reid JL.
    Br Heart J; 1991 Sep 16; 66(3):206-11. PubMed ID: 1657084
    [Abstract] [Full Text] [Related]

  • 27. Effects of enalapril maleate (MK-421) on renovascular hypertension.
    Ogawa K, Matsunaga M, Nagai H, Hara A, Koide H, Pak CH, Hirakawa A, Kawai C.
    Tohoku J Exp Med; 1985 Feb 16; 145(2):125-35. PubMed ID: 2986316
    [Abstract] [Full Text] [Related]

  • 28. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
    Fitzpatrick D, Nicholls MG, Ikram H, Espiner EA.
    Br Heart J; 1983 Aug 16; 50(2):163-9. PubMed ID: 6309203
    [Abstract] [Full Text] [Related]

  • 29. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
    Sweet CS, Arbegast PT, Gaul SL, Blaine EH, Gross DM.
    Eur J Pharmacol; 1981 Dec 03; 76(2-3):167-76. PubMed ID: 6174351
    [Abstract] [Full Text] [Related]

  • 30. Antihypertensive effect of enalapril as first-step treatment of mild and moderate uncomplicated essential hypertension. Evaluation by two methods of blood pressure measurement.
    Sassano P, Chatellier G, Alhenc-Gelas F, Corvol P, Menard J.
    Am J Med; 1984 Aug 20; 77(2A):18-22. PubMed ID: 6089555
    [Abstract] [Full Text] [Related]

  • 31. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS.
    Fed Proc; 1983 Feb 20; 42(2):167-70. PubMed ID: 6295819
    [Abstract] [Full Text] [Related]

  • 32. Enalapril and atenolol in primary hypertension--a comparative study of blood pressure lowering and hormonal effects.
    Ohman KP, Karlberg BE.
    Scand J Urol Nephrol Suppl; 1984 Feb 20; 79():93-7. PubMed ID: 6089325
    [Abstract] [Full Text] [Related]

  • 33. Serum concentration and effects of a single dose of enalapril maleate in patients with essential hypertension.
    Shionoiri H, Gotoh E, Miyazaki N, Yasuda G, Takagi N, Uneda S, Kaneko Y.
    Jpn Circ J; 1985 Jan 20; 49(1):46-51. PubMed ID: 2982051
    [Abstract] [Full Text] [Related]

  • 34. The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.
    Broughton Pipkin F, Wallace CP.
    Br J Pharmacol; 1986 Mar 20; 87(3):533-42. PubMed ID: 3026539
    [Abstract] [Full Text] [Related]

  • 35. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations.
    DiCarlo L, Chatterjee K, Parmley WW, Swedberg K, Atherton B, Curran D, Cucci M.
    J Am Coll Cardiol; 1983 Nov 20; 2(5):865-71. PubMed ID: 6313787
    [Abstract] [Full Text] [Related]

  • 36. Initial evaluation of the non-sulfhydryl-containing converting enzyme inhibitor MK-521 in hypertensive humans.
    Rotmensch HH, Vincent M, Vlasses PH, Swanson BN, Irvin JD, Hichens M, Harris KE, Ferguson RK.
    Fed Proc; 1984 Apr 20; 43(5):1333-5. PubMed ID: 6323225
    [Abstract] [Full Text] [Related]

  • 37. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J.
    Circulation; 1995 Aug 15; 92(4):825-34. PubMed ID: 7641363
    [Abstract] [Full Text] [Related]

  • 38. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A, Dunne B, Glazer N, Kostis JB, Miller WE, Rector DJ, Tresznewsky ON.
    J Hum Hypertens; 1992 Aug 15; 6(4):325-31. PubMed ID: 1331444
    [Abstract] [Full Text] [Related]

  • 39. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O, Bao G, Feelisch M, Unger T, Gohlke P.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):854-63. PubMed ID: 7473177
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats.
    DiNicolantonio R, Doyle AE.
    J Cardiovasc Pharmacol; 1985 Nov 15; 7(5):937-42. PubMed ID: 2413304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.